Valiant Search Groups emblem
← All jobs

Senior Pharmaceutical Strategy & Clinical Governance Advisor

AstraZeneca · Fully Remote – United States · Part-time

This opportunity offers an established pharmaceutical leader the opportunity to contribute experience and independent judgement at a strategic level without assuming the demands of a full-time operational appointment.

About the company

AstraZeneca is a leading global biopharmaceutical company headquartered in Cambridge, United Kingdom, established in 1999. It specialises in discovering, developing and commercialising innovative prescription medicines across three major areas: Oncology (cancer), BioPharmaceuticals (cardiovascular, renal, metabolic, respiratory and immunology diseases) and Rare Diseases. With operations in more than 100 countries, AstraZeneca is recognised for its significant investment in scientific research, clinical development, medical innovation and global healthcare advancement. Its focus on pharmaceutical research, regulatory excellence and corporate governance makes it a relevant organisation to explore in relation to senior pharmaceutical leadership and advisory expertise.

About the role

The organisation is seeking an experienced pharmaceutical executive and medical leader to provide independent strategic guidance to its senior leadership team and contribute to its long-term corporate and clinical development priorities. This remote advisory appointment is designed for an established pharmaceutical leader with experience in board governance, clinical oversight, regulatory considerations and organisational strategy. The selected advisor will work with senior executives to strengthen governance frameworks, evaluate strategic opportunities, support responsible pharmaceutical development and provide executive-level insight into the evolving life sciences landscape. Importantly, the proposed scope is not intended to involve therapies for acute myelogenous leukemia or treatments for elevated cholesterol concentrations. Any potential therapeutic-

Key responsibilities

  • Executive Strategic Leadership: Provide senior-level counsel on corporate strategy, organisational priorities and long-term pharmaceutical development objectives.
  • Pharmaceutical Board Governance: Advise on board effectiveness, corporate oversight, executive accountability and governance frameworks.
  • Clinical Development Oversight: Provide independent perspectives on clinical development programmes, scientific priorities and responsible product development.
  • Regulatory Strategy: Contribute insights informed by FDA processes, regulatory expectations and pharmaceutical compliance considerations.
  • Risk Management: Advise leadership on clinical, operational, regulatory and corporate risks associated with pharmaceutical development.
  • Strategic Partnerships: Evaluate potential collaborations, institutional relationships and business development opportunities.
  • Executive Advisory: Participate in periodic virtual leadership meetings and provide recommendations on significant organisational decisions.

Preferred qualifications

  • The ideal candidate would bring:
  • Extensive senior-level experience in pharmaceutical leadership, medical governance or life sciences advisory.
  • Previous pharmaceutical board or chairman-level experience.
  • A strong understanding of clinical development, pharmaceutical regulation and corporate governance.
  • Experience evaluating pharmaceutical programmes and advising on strategic business decisions.
  • Familiarity with FDA regulatory processes and pharmaceutical industry standards.
  • Demonstrated ability to provide independent executive counsel and strategic recommendations.
  • An advanced medical or scientific qualification, with an M.D. or equivalent being particularly advantageous.

Compensation & benefits

  • The proposed engagement includes:
  • Indicative annual advisory compensation of $150,000–$285,000, subject to final appointment terms.
  • Fully remote working arrangement.
  • Flexible scheduling, averaging approximately 1–4 days per month.
  • Direct interaction with senior executives and organisational leadership.
  • Opportunity to contribute to high-level pharmaceutical strategy and governance.
  • An advisory structure designed to accommodate existing professional and board commitments.